Business Wire | Jun 23, 2021 04:42PM EDT

Adamas to Present at Upcoming SVB Leerink CNS Forum

Jun. 23, 2021

EMERYVILLE, Calif.--(BUSINESS WIRE)--Jun. 23, 2021--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present "What's Happening in Parkinson's Disease & the GOCOVRI Opportunity" at the SVB Leerink CNS Forum on Tuesday, June 29th at 1:10 pm Eastern Time.

The presentation will be broadcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Replays of the event will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear - to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210623005941/en/

CONTACT: Media: Sarah Mathieson Vice President, Corporate Communications 510-450-3528 smathieson@adamaspharma.com Investors: Peter Vozzo Managing Director Westwicke/ICR 443-213-0505 peter.vozzo@westwicke.com